US Patent 7384959 Treatment of convulsive states
All edits
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+185 characters)
Article
Patent abstract
Single enantiomer-threo-methylphenidate is useful in the therapy of a convulsant state, e.g. epilepsy, a bipolar disorder or narcolepsy. It may be administered topically.
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07384959 Treatment of convulsive states US Patent 7384959 Treatment of convulsive states
Infobox
Patent Number
0738495900
Patent Number
738495900
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073849590
Date of Patent
June 10, 2008
0Patent Application Number
101485350
Date Filed
December 15, 2000
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073849590
Date of Patent
June 10, 2008
0Patent Application Number
101485350
Date Filed
December 15, 2000
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07384959 Treatment of convulsive states
Infobox
Is a
Patent jurisdiction
Patent number
07384959
Date of patent
June 10, 2008
Patent application number
10148535
Date Filed
December 15, 2000
Patent primary examiner
Find more entities like US Patent 7384959 Treatment of convulsive states
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
